Abstract
Pro-protein convertase subtilisin/Kexin type 9 (PCSK9) inhibitors are relatively new, non-statin, lipid-lowering drugs that reduce low-density lipopro......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
